Obesity diminishes response to PD-1-based immunotherapies in renal cancer.
Boi SK, Orlandella RM, Gibson JT, Turbitt WJ, Wald G, Thomas L, Buchta Rosean C, Norris KE, Bing M, Bertrand L, Gross BP, Makkouk A, Starenki D, Farag KI, Sorge RE, Brown JA, Gordetsky J, Yasin H, Garje R, Nandagopal L, Weiner GJ, Lubaroff DM, Arend RC, Li P, Zakharia Y, Yang E, Salem AK, Nepple K, Marquez-Lago TT, Norian LA.
Boi SK, et al. Among authors: orlandella rm.
J Immunother Cancer. 2020 Dec;8(2):e000725. doi: 10.1136/jitc-2020-000725.
J Immunother Cancer. 2020.
PMID: 33427691
Free PMC article.